Back
Ionis Pharmaceuticals Quote, Financials, Valuation and Earnings
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!
Sell
22
IONS
Ionis Pharmaceuticals
Last Price:
37.91
Seasonality Move:
6.36%
7 Day Trial
ALL ACCESS PASS
$
7
Supercharge Your Portfolio with This High-Traction AI Startup
Learn MoreIonis Pharmaceuticals Price Quote
$37.91
Ionis Pharmaceuticals Key Stats
Sell
22
Ionis Pharmaceuticals (IONS)
is a Sell
Day range:
$37.12 - $38.02
52-week range:
$35.95 - $54.44
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.74
P/B ratio:
22.67%
Volume:
1.3M
Avg. volume:
2.1M
1-year change:
-13.19%
Market cap:
$6B
Revenue:
$787.6M
EPS:
$-2.52
How Much Does Ionis Pharmaceuticals Make?
-
How Much Are Ionis Pharmaceuticals's Sales Annually?
IONS Revenues are $787.6M -
How Much Profit Does Ionis Pharmaceuticals's Make A Year?
IONS net income is -$366.3M
Is Ionis Pharmaceuticals Growing As A Company?
-
What Is Ionis Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.2% -
What Is Ionis Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ionis Pharmaceuticals Stock Price Performance
-
Did Ionis Pharmaceuticals Stock Go Up Last Month?
Ionis Pharmaceuticals share price went down by -20.44% last month -
Did IONS's Share Price Rise Over The Last Year?
IONS share price fell by -13.19% over the past 1 year
What Is Ionis Pharmaceuticals 52-Week High & Low?
-
What Is Ionis Pharmaceuticals’s 52-Week High Share Price?
Ionis Pharmaceuticals has traded as high as $54.44 over the past 52 weeks -
What Is Ionis Pharmaceuticals’s 52-Week Low Share Price?
Ionis Pharmaceuticals has traded as low as $35.95 over the past 52 weeks
Ionis Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ionis Pharmaceuticals?
-
How Much Debt Does Ionis Pharmaceuticals Have?
Total long term debt quarterly is $1.3B -
How Much Cash Does Ionis Pharmaceuticals Have?
Cash and short term investments quarterly total is $2.1B -
What Is Ionis Pharmaceuticals’s Book Value Per Share?
Book value per share is 1.81
Is Ionis Pharmaceuticals Cash Flow Positive?
-
What Is IONS Cash Flow From Operations?
Cash flow from operations (TTM) is -$346M -
What Is Ionis Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $34.6M -
What Is Ionis Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $180.6M
Ionis Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
IONS return on invested capital is -22.52% -
What Is Ionis Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -12.74% -
What Is IONS Return On Equity?
ROE is a measure of profitability and is -108.17%
Ionis Pharmaceuticals Earnings Date & Stock Price
-
What Is Ionis Pharmaceuticals's Stock Price Today?
A single share of IONS can be purchased today for 37.91 -
What Is Ionis Pharmaceuticals’s Stock Symbol?
Ionis Pharmaceuticals trades on the nasdaq under the ticker symbol: IONS -
When Is Ionis Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Ionis Pharmaceuticals is scheduled on November 1, 2024 -
When Is IONS's next ex-dividend date?
Ionis Pharmaceuticals's next ex-dividend date is October 6, 2024 -
How To Buy Ionis Pharmaceuticals Stock?
You can buy Ionis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ionis Pharmaceuticals Competitors
-
Who Are Ionis Pharmaceuticals's Competitors?
Below is a list of companies who compete with Ionis Pharmaceuticals or are related in some way:
Ionis Pharmaceuticals Dividend Yield
-
What Is IONS Dividend Yield?
Ionis Pharmaceuticals’s dividend yield currently is 0% -
What Is Ionis Pharmaceuticals’s Payout Ratio?
Ionis Pharmaceuticals’s payout ratio is 0% -
When Did Ionis Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is October 6, 2024 -
What Is Ionis Pharmaceuticals’s Dividend Per Share?
Ionis Pharmaceuticals pays a dividend of $0.00 per share
Ionis Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 68.59% |
| Revenue: | 19.55% | 50.21% |
Analyst Recommendations
| Buy Recommendations: | 12 |
|---|---|
| Hold Recommendations: | 7 |
| Sell Recommendations: | 0 |
| Price Target: | 62.67 |
| Upside from Last Price: | 65.31% |